Cystoid macular edema (CME) continues to be an important complication after cataract surgery and other ophthalmological interventions. Indeed, this collateral effect represents the main cause of decreased visual acuity after phacoemulsification, even in uneventful surgeries and in patients without additional risks factors [1]. Although the frequency of clinically significant CME may vary from 0...

Background: Diabetic retinopathy (DR) is one of the leading causes vision loss which occurs as a result microvascular complication diabetes. The aim study to assess prevalence and factors associated with development diabetic among patients attending eye camps in hospital northern Bangladesh. Methods: This was population-based cross-sectional study, conducted through five comprehensive at associ...

PURPOSE To describe the changes in retinal vascular caliber in response to a single injection of intravitreal triamcinolone (IVTA) in patients with refractory diabetic macular edema. METHODS Prospective data from a randomized clinical trial were used. The effects of IVTA versus sham injections in patients with refractory diabetic macular edema were evaluated in a randomized clinical trial inv...

PURPOSE To compare the visual acuity and macular thickness in patients with diabetic retinopathy presenting and not presenting macular edema before treatment and submitted to argon laser retinal panphotocoagulation. METHODS Patients were included and classified into two groups before the treatment. All patients were submitted to ophthalmological examination and optical coherence tomography, f...

Diabetes mellitus is a major cause of blindness in the working population of the Western World. Numerous large, prospective, randomized clinical trials have delineated the current standard prevention and treatment protocols including intensive glycemic and blood pressure control as well as laser photocoagulation for clinically significant macular edema and/or proliferative retinopathy at a high...

In type I (insulin-dependent) diabetes mellitus, nephropathy may be identified in its early stages by the development of persistent microalbuminuria. This longitudinal study sought to examine the development of vision-threatening retinal disease (VTRD) (proliferative retinopathy and clinically significant macular edema) in such patients with early and evolving diabetic kidney disease. Eighty pa...

OBJECTIVE To determine whether sequence variation in the erythropoietin gene (EPO) is associated with the development of diabetic retinopathy (DR). METHODS This was a multicenter study based on 518 subjects with long-standing diabetes mellitus (DM), 173 with type 1 DM (T1DM) and 345 with type 2 DM (T2DM). Study groups consisted of 233 control subjects with no DR, 155 subjects with nonprolifer...

OBJECTIVE To evaluate the validity and reproducibility of software for reading digital images and grading diabetic retinopathy. RESEARCH DESIGN AND METHODS A prospective, comparative observational study was conducted on a series of patients with type 2 diabetes who presented at the retina clinic of a tertiary care center in India. A total of 210 eyes of 105 patients were allocated to one of t...

purpose : central retinal vein occlusion (crvo) is the most common vascular event in the eye after diabetic retinopathy. this study was conducted to evaluate the effect of intravitreal triamcinolone (ivt) on acute crvo. materials & methods : in a randomized sham-controlled clinical trial, 27 eyes with recent onset (less than 2 months) crvo were randomly assigned to two groups. the treatment gro...

Diabetic retinopathy is a common microvascular complication of diabetes mellitus and one the leading causes acquired blindness. Microalbuminuria reflects pathophysiological state vascular dysfunction organ damage. It noticed that rise in urinary albumin excretion seen early phase diabetic retinopathy. The concordance microalbuminuria has been well reported type 1 diabetes; however, for 2 diabet...